Stay updated on HMPL-523 in ITP Patients: Safety, PK, Efficacy Clinical Trial
Sign up to get notified when there's something new on the HMPL-523 in ITP Patients: Safety, PK, Efficacy Clinical Trial page.

Latest updates to the HMPL-523 in ITP Patients: Safety, PK, Efficacy Clinical Trial page
- Check4 days agoChange DetectedThe footer now identifies the ClinicalTrials.gov site revision as v3.8.0 instead of v3.7.2.SummaryDifference0.2%

- Check11 days agoChange DetectedA notice announces that NIH is transitioning from the term “Artificial Intelligence” to “Super Intelligence” across its content.SummaryDifference1%

- Check18 days agoChange DetectedThe footer revision identifier changes from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check25 days agoChange DetectedThe ClinicalTrials.gov footer now shows revision v3.7.1 instead of v3.7.0; the study record still displays a 403 Forbidden page.SummaryDifference0.2%

- Check46 days agoChange DetectedThe page now displays a 403 Forbidden error with a bare header, indicating that access to the study content is blocked rather than showing the expected study details.SummaryDifference18%

- Check67 days agoChange DetectedThe page footer revision label updated from v3.6.5 to v3.6.6, signaling a minor platform update. This change does not alter the study details or how users interact with the page.SummaryDifference0.1%

Stay in the know with updates to HMPL-523 in ITP Patients: Safety, PK, Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HMPL-523 in ITP Patients: Safety, PK, Efficacy Clinical Trial page.